Health Catalyst (HCAT) Stock Price
Health Catalyst Price
Revenue has compounded at 19.1% per year over the past 8 years to 286.88 M USD. Health Catalyst's net margin stands at -62.0%, up from -68.2% several years earlier. Analysts set a median price target of 2.38 USD, implying 62.7% above the current price. Of 11 analysts, 6 rate the stock a buy — an overall Buy consensus.
Health Catalyst stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Health Catalyst business model & stock analysis
Frequently asked questions about Health Catalyst
The business model of Health Catalyst Inc is focused on providing data and analytics solutions to healthcare organizations. The company aims to enable these organizations in improving patient outcomes, reducing costs, and enhancing operational efficiency by leveraging their vast amount of healthcare data. Health Catalyst offers a comprehensive suite of products and services, including a data platform, analytics applications, and expertise in areas such as quality measures, population health management, and care coordination. By utilizing advanced data analytics, Health Catalyst assists healthcare organizations in making informed decisions, identifying areas for improvement, and ultimately transforming the way healthcare is delivered.
Health Catalyst Inc is primarily active in the healthcare industry.
Some of the main competitors of Health Catalyst Inc in the market include Cerner Corporation, Epic Systems Corporation, Allscripts Healthcare Solutions, and McKesson Corporation.
Health Catalyst Inc is a leading provider of data and analytics in the healthcare industry. Founded in 2008, the company has quickly gained prominence for its innovative approach to improving healthcare outcomes through data-driven insights. Health Catalyst offers a comprehensive suite of solutions designed to help healthcare organizations organize, analyze, and leverage their data to drive decision-making and improve patient care. With a strong focus on value-based care and population health management, Health Catalyst has established itself as a trusted partner for healthcare organizations seeking to transform their operations and achieve better patient outcomes.
Health Catalyst Inc, a leading healthcare analytics and data warehousing company, has achieved several significant milestones. Notably, the company successfully completed its initial public offering in July 2019, raising approximately $182 million. In 2020, Health Catalyst was named one of the Best Places to Work in Healthcare by Modern Healthcare. Furthermore, the company has consistently expanded its customer base, delivering data-driven solutions to over 150 healthcare organizations. Health Catalyst's innovative use of artificial intelligence and machine learning technologies has also gained recognition, contributing to the company's growth and success in improving healthcare outcomes.
Health Catalyst Inc is primarily present in the United States.
Health Catalyst Inc is a leading provider of data and analytics solutions for healthcare organizations. The company represents values such as innovation, collaboration, and a patient-centric approach. With a focus on improving healthcare outcomes, Health Catalyst Inc emphasizes the importance of data-driven decision-making and empowering healthcare professionals with actionable insights. Their corporate philosophy revolves around driving meaningful change in the healthcare industry through leveraging advanced analytics and technology. By offering transformative solutions, Health Catalyst Inc aims to enable healthcare organizations to deliver better patient care, reduce costs, and enhance operational efficiency.
Analysts currently set an average price target of 2.38 USD for the Health Catalyst stock (median: 2.38 USD), implying +63.0 % versus the latest price. The consensus is based on 11 analyst ratings.
11 analysts currently rate the Health Catalyst stock: 6 recommend buying, 5 holding and 0 selling. For 2026, analysts expect Health Catalyst to generate revenue of 247.81 M USD and earnings per share of -0.04 USD.
Converted at the current exchange rate, the Health Catalyst share trades at 1.31 EUR (1.46 USD).
The Health Catalyst share (HCAT) is listed on 2 stock exchanges, including: NASDAQ (HCAT), Frankfurt (2YP.F).
Health Catalyst Inc is a US-based company specializing in the development of clinical analytics platforms. The company offers solutions for healthcare data analysis and data-driven decision support. Its business model is based on providing software and analytics tools to manage, integrate, analyze, and visualize clinical data. By combining the latest technologies in data analytics and business intelligence with deep expertise in healthcare, Health Catalyst supports hospitals and health systems in improving patient care. The company consists of two main divisions: data warehousing and analytics. The data warehousing division involves developing and managing databases and integrating data from various sources to obtain a comprehensive view of a facility's clinical performance and enable informed decision-making. The analytics division focuses on implementing analytics tools and methods to analyze the collected data and transform it into meaningful insights. Health Catalyst's product range includes solutions for population health management, improving clinical outcomes, and reducing healthcare costs. This includes clinical analytics and visualization tools, population health management platforms, data integration and storage solutions, and healthcare analytics services. The Health Catalyst data platform is an open system capable of processing both structured and unstructured data in real-time. This allows customers to easily integrate and analyze their data for informed decision-making. The target customers of Health Catalyst are hospitals and health systems in the United States facing increasing competitive pressure and growing demand for high-quality patient care. The company addresses the need to reduce healthcare costs, improve patient care, and optimize health processes. Health Catalyst's business model relies on recurring revenue from selling subscriptions to use the software platform and providing analytics tools and services. Additionally, the company offers training, consulting services, and technical support. In summary, Health Catalyst creates value for its customers by providing advanced tools to improve healthcare and achieve cost savings. The company's business model is also focused on recurring subscription revenue and additional service fees. By focusing on improving clinical outcomes, Health Catalyst demonstrates enthusiasm for healthcare and a passionate commitment to enhancing patient well-being.
The expected revenue of Health Catalyst is 247.81 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Health Catalyst is -2.51 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Health Catalyst is currently -41.22. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Health Catalyst stock.
The price-to-sales ratio (P/S) of Health Catalyst is currently 0.42. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Health Catalyst stock.
The Eulerpool Quality Score for Health Catalyst is 2/10.
The ISIN of Health Catalyst is US42225T1079. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Health Catalyst is A2PH3J. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Health Catalyst is HCAT. The ticker symbol is used to trade Health Catalyst shares on the stock exchange.
Health Catalyst stock
Health Catalyst Peer Group
Health Catalyst Ticker
Health Catalyst FIGI
All fundamentals and in-depth analysis of Health Catalyst
Our stock analysis for Health Catalyst stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Health Catalyst. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.